ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
US FDA grants EUA to Regeneron’s antibody cocktail for Covid-19
November 23, 2020The US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) to Regeneron Pharmaceuticals’ antibody cocktail casirivimab and imdevimab for treating patients with mild to moderate Covid-19. -
US FDA grants EUA to monoclonal antibodies from Regeneron for COVID-19 treatment
November 23, 2020In a clinical trial, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalisation or emergency room visits in patients at high risk for disease progression within 28 days after treatment.
Pharma Sources Insight January 2025
